Reduction of catheter-related bloodstream infections through the use of a central venous line bundle: Epidemiologic and economic consequences

American Journal of Infection Control

Volumn 39, Issue 8, 2011, Pages 640-646

  Kim, James S ^a   Holtom, Paul ^a   Vigen, Cheryl ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

bundle; Catheter related bloodstream infections; cost control; CRBSI

Indexed keywords

AMPHOTERICIN B; AMPICILLIN; ANTIBIOTIC AGENT; CARBAPENEM; CEFEPIME; CEFTRIAXONE; CLINDAMYCIN; COLISTIMETHATE; DAPTOMYCIN; ECHINOCANDIN; FLUCONAZOLE; GENTAMICIN; MICAFUNGIN; OXACILLIN; PENICILLIN DERIVATIVE; SULTAMICILLIN; TIGECYCLINE; TOBRAMYCIN; VANCOMYCIN;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIAL INFECTION; BLOODSTREAM INFECTION; CANDIDA; CANDIDIASIS; CATHETER INFECTION; CENTRAL VENOUS CATHETER; CLINICAL PRACTICE; COST CONTROL; DRUG CHOICE; DRUG COST; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEALTH CARE COST; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INFECTION RATE; INFECTION RISK; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NONHUMAN; PATIENT CARE; PRACTICE GUIDELINE; RISK REDUCTION; VANCOMYCIN RESISTANT ENTEROCOCCUS;

BACTEREMIA; CATHETER-RELATED INFECTIONS; CATHETERIZATION, CENTRAL VENOUS; COST-BENEFIT ANALYSIS; CROSS INFECTION; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HEALTH CARE COSTS; HUMANS; INFECTION CONTROL; INTENSIVE CARE UNITS; LENGTH OF STAY; PROGRAM EVALUATION;

EID: 80053569592     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2010.11.005     Document Type: Article

References (28)

1. N.P. O'Grady, M. Alexander, E.P. Dellinger, J.L. Gerberding, S.O. Heard, and D.G. Maki Guidelines for the prevention of intravascular catheter-related infections Clin Infect Dis 35 2002 1281 1307 (Pubitemid 35448956)
2. P. Pronovost, D. Needham, S. Berenholtz, D. Sinopoli, H. Chu, and S. Cosgrove An intervention to decrease catheter-related bloodstream infections in the ICU N Engl J Med 355 2006 2725 2732 (Pubitemid 46021509)
3. L. Soufir, J. Timsit, C. Mahe, J. Carlet, B. Regnier, and S. Chevret Attributable morbidity and mortality of catheter-related septicemia in critically ill patients: a matched, risk adjusted, cohort study Infect Control Hosp Epidemiol 20 1999 396 401
4. J.R. Edwards, K.D. Peterson, Y. Mu, S. Banerjee, K. Allen-Bridson, and G. Morrell National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009 Am J Infect Control 37 2009 783 805
5. C.M. Coopersmith, T.L. Rebmann, J.E. Zack, M.R. Ward, R.M. Corcoran, and M.E. Schallom Effect of an education program on decreasing catheter-related bloodstream infections in the surgical intensive care unit Crit Care Med 30 2002 59 64 (Pubitemid 34112177)
6. D. Berriel-Cass, F.W. Adkins, P. Jones, and M.G. Fakih Eliminating nosocomial infections at ascension health Jt Comm J Qual Patient Saf 32 2006 612 620
7. J. Merrer, B. De Jonghe, F. Golliot, J.Y. Lefrant, B. Raffy, and E. Barre Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial JAMA 286 2001 700 707 (Pubitemid 33010363)
8. Raad II, D.C. Hohn, B.J. Gilbreath, N. Suleiman, L.A. Hill, and P.A. Bruso Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion Infect Control Hosp Epidemiol 15 1994 231 238
9. J.I. Sznajder, F.R. Zveibil, H. Bitterman, P. Weiner, and S. Bursztein Central vein catheterization: failure and complication rates by three percutaneous approaches Arch Intern Med 146 1986 259 261 (Pubitemid 16018539)
10. C. Martin, B. Eon, J.P. Auffray, P. Saux, and F. Gouin Axillary or internal jugular central venous catheterization Crit Care Med 18 1990 400 402 (Pubitemid 20138319)
11. O. Durbec, X. Viviand, F. Potie, R. Vialet, J. Albanese, and C. Martin A prospective evaluation of the use of femoral venous catheters in critically ill adults Crit Care Med 25 1997 1986 1989 (Pubitemid 28007235)
12. IHI.org. Cambridge, MA: Institute for Healthcare Improvement. (updated September 6, 2006). Available from: http://www.ihi.org/IHI/Topics/CriticalCare/ IntensiveCare/ImprovementStories/WhatIsaBundle.htm. Accessed April 13, 2009.
13. IHI.org. Cambridge, MA: Institute for Healthcare Improvement. (updated September 6, 2006). Available from: http://www.ihi.org/IHI/Topics/CriticalCare/ IntensiveCare/Changes/ImplementtheCentralLineBundle.htm. Accessed April 13, 2009.
14. D. Galpern, A. Guerrero, A. Tu, B. Fahoum, and L. Wise Effectiveness of a central line bundle campaign on line-associated infections in the intensive care unit Surgery 144 2008 492 495
15. P. Eggimann, S. Harbarth, M.N. Constantin, S. Touveneau, J.C. Chevrolet, and P. Pittet Impact of a prevention strategy targeted at vascular-access care on incidence of infections acquired in intensive care Lancet 355 2000 1864 1868 (Pubitemid 30311878)
16. R.S. Bonello, C.E. Fletcher, W.K. Becker, K.L. Clutter, S.L. Arjes, and J.J. Cook An intensive care unit quality improvement collaborative in nine Department of Veterans Affairs hospitals: reducing ventilator-associated pneumonia and catheter-related blood stream infections Jt Comm J Qual Patient Saf 34 2008 639 645
17. M.L. Render, S. Brungs, U. Kotagal, M. Nicholson, P. Burns, and D. Ellis Evidence-based practice to reduce central line infections Jt Comm J Qual Patient Saf 32 May 2006 253 260
18. S.M. Berenholtz, P.J. Pronovost, P.A. Lipsett, D. Hobson, K. Earsing, and J.E. Farley Eliminating catheter-related bloodstream infections in the intensive care unit Crit Care Med 32 2004 2014 2020 (Pubitemid 39372534)
19. K.K. Hu, D.L. Veenstra, B.A. Lipsky, and S. Saint Use of maximal sterile barriers during central venous catheter insertion: clinical and economic outcomes Clin Infect Dis 39 2004 1441 1445 (Pubitemid 39518206)
20. D. Pittet, D. Tarara, and R.P. Wenzel Nosocomial bloodstream infection in critically ill patients: excess length of stay, extra costs, and attributable mortality JAMA 271 1994 1598 1601
21. S. Saint, D.L. Veenstra, and B.A. Lipsky The Clinical and economic consequences of nosocomial central venous catheter-related infection: are antimicrobial catheters useful? Infect ControlHosp Epidemiol 21 2000 375 380
22. L.A. Mermel, B.M. Farr, R.J. Sherertz, Raad II, N. O'Grady, and J.S. Harris Guidelines for management of intravascular catheter-related infections CID 32 2001 1249 1272 (Pubitemid 32405897)
23. L.L. Maragakis, and T.M. Perl Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options Clin Infect Dis 46 2008 1254 1263 (Pubitemid 351589912)
24. V.M. Manikal, D. Landman, G. Saurina, E. Oydna, H. Lal, and J. Quale Endemic carbapenem-resistant Acinetobacter species in Brooklyn: city-wide prevalence, interinstitutional spread, and relation to antibiotic usage CID 31 2000 101 106 (Pubitemid 32268946)
25. S. Beekman, and D. Henderson Infections caused by percutaneous intravascular devices G. Mandell, J. Bennett, R. Dolin, Principles and practice of infectious diseases 6th ed. 2005 Churchill Livingstone New York 3347 3362
26. A. Soriano, F. Marco, J.A. Martinez, E. Pisos, M. Almela, and P.D. Veselka Influence of vancomycin minimum inhibitory concentration on the treatment of methicillin-resistant Staphylococcus aureus bacteremia Clin Infect Dis 46 2008 193 200 (Pubitemid 351269157)
27. J. Rodriguez-Bano, M.D. Navarro, L. Romero, M.A. Muniain, M. de Cueto, and M.J. Rios Bacteremia due to extended-spectrum β-lactamase producing Escherichia coli in the CTX-M era: a new clinical challenge Clin Infect Dis 43 2006 1407 1414 (Pubitemid 44845640)
28. A.K. Meagher, P.G. Ambrose, T.H. Grasela, and E.J. Ellis-Grosse The pharmacokinetic and pharmacodynamic profile of tigecycline Clin Infect Dis 41 2005 S333 S340